|
Trexan Neo 2,5 mg tablety tbl 60x2,5 mg (blis.PVC/Al)
2,5 mg
|
Tableta |
L04AX03
|
Orion Corporation |
—
|
|
Trexan Neo 2,5 mg tablety tbl 8x2,5 mg (blis.PVC/Al)
2,5 mg
|
Tableta |
L04AX03
|
Orion Corporation |
—
|
|
Verimmus 10 mg tablety tbl 10x10 mg (blis.OPA/Al/PVC/Al)
10 mg
|
Tableta |
L01EG02
|
Egis Pharmaceuticals PLC |
—
|
|
Verimmus 10 mg tablety tbl 30x10 mg (blis.OPA/Al/PVC/Al)
10 mg
|
Tableta |
L01EG02
|
Egis Pharmaceuticals PLC |
—
|
|
Verimmus 10 mg tablety tbl 90x10 mg (blis.OPA/Al/PVC/Al)
10 mg
|
Tableta |
L01EG02
|
Egis Pharmaceuticals PLC |
—
|
|
Verimmus 5 mg tablety tbl 10x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
Egis Pharmaceuticals PLC |
—
|
|
Verimmus 5 mg tablety tbl 30x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
Egis Pharmaceuticals PLC |
—
|
|
Verimmus 5 mg tablety tbl 90x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
Egis Pharmaceuticals PLC |
—
|
|
Vesanoid 10 mg cps mol 100x10 mg (liek.skl.hnedá)
10 mg
|
Mäkká kapsula |
L01XF01
|
CHEPLAPHARM Arzneimittel GmbH |
—
|
|
Vinorelbine Accord 10 mg/ml koncentrát na infúzny roztok con inf 1x1 ml (liek.inj.skl.)
10 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CA04
|
Accord Healthcare Polska Sp. z o.o. |
—
|
|
Vinorelbine Accord 10 mg/ml koncentrát na infúzny roztok con inf 1x5 ml (liek.inj.skl.)
10 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CA04
|
Accord Healthcare Polska Sp. z o.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 1x20 mg (blis.Al/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 1x20 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 4x20 mg (blis.Al/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 4x20 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 1x30 mg (blis.Al/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 1x30 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 4x30 mg (blis.Al/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 4x30 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine medac 20 mg mäkké kapsuly cps mol 1x20 mg (blis.PVC/PVDC/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Vinorelbine medac 20 mg mäkké kapsuly cps mol 4x1x20 mg (blis.PVC/PVDC/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Vinorelbine medac 30 mg mäkké kapsuly cps mol 1x30 mg (blis.PVC/PVDC/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Vinorelbine medac 30 mg mäkké kapsuly cps mol 4x1x30 mg (blis.PVC/PVDC/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Weldinin tbl flm 112x200 mg (blis.Al/PVC/PE/PVDC-kalend.)
200 mg
|
Filmom obalená tableta |
L01EX02
|
Egis Pharmaceuticals PLC |
—
|